Delivery Order SPE2DB20D3104-SPE2DB24FV7N3

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,118.13 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a prescription insulin product. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,323.14 firm fixed-price delivery order is for Humulin R 500 unit/mL Kwikpen 3mL, a type of insulin medication. The contract has a completion date of February 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,303.44, is for the supply of Humulin R 500 Unit/mL KwikPen 3mL, a pharmaceutical product used for the management of diabetes. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The $4,472.64 Firm Fixed Price contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a type of insulin medication. This Delivery Order does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,655.32, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Humulin R 500 unit/mL KwikPen 3 mL, a type of insulin medication. This is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is June 3, 2024. Amerisourcebergen Drug Corp holds a significant single-award Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Humulin R 500 Unit/mL KwikPen insulin injectors. The $4,163.44 firm fixed-price contract has a performance period through March 24, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,247.60, is for the delivery of Humulin R 500 unit/mL Kwikpen 3mL, a specialized insulin medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 28, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,609.04, is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has a performance period extending to September 11, 2024 and is a firm-fixed-price contract. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,660.01 firm fixed-price contract is for the supply of Humulin R 500 Unit/mL Kwikpen 3mL, a medication used to treat diabetes. The contract has an ultimate completion date of March 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is valued at $11,929.14 and is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV7N3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,236.32 firm-fixed-price contract is for the supply of Humulin R 500 unit/mL KwikPen 3 mL, a prescription insulin medication. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/12/24, 11:29 AM